Evidence map›Paper›PMID 33491136›Full record

ArticleAnnals of hematology2021

Paroxysmal nocturnal hemoglobinuria complicated with essential thrombocythemia harboring concomitant PIGA, CALR, and ASXL1 mutations.

Haruya Okamoto, Nobuhiko Uoshima, Yuri Kamitsuji, Eri Kawata, Yukiko Komori, Nana Sasaki, Yasuhiko Tsutsumi, Taku Tsukamoto, Shinsuke Mizutani, Yasuhito Nannya and 1 more

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in Annals of hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Haruya OkamotoDivision of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
Nobuhiko UoshimaDepartment of Hematology, Japan Red Cross Hospital Kyoto Daini, Kyoto, Japan.
Yuri KamitsujiDepartment of Hematology, Japan Red Cross Hospital Kyoto Daini, Kyoto, Japan.
Eri KawataDepartment of Hematology, Japan Red Cross Hospital Kyoto Daini, Kyoto, Japan.
Yukiko KomoriDepartment of Hematology, Japan Red Cross Hospital Kyoto Daini, Kyoto, Japan.
Nana SasakiDepartment of Hematology, Japan Red Cross Hospital Kyoto Daini, Kyoto, Japan.
Yasuhiko TsutsumiDepartment of Hematology, Japan Red Cross Hospital Kyoto Daini, Kyoto, Japan.
Taku TsukamotoDivision of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
Shinsuke MizutaniDivision of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
Yasuhito NannyaDepartment of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Junya KurodaDivision of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan. junkuro@koto.kpu-m.ac.jp.ORCID http://orcid.org/0000-0001-6130-1550
Japanese Red Cross Society Kyoto Daini Hospital · JPKyoto Prefectural University of Medicine · JPKyoto University · JPMatsushita Memorial Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CalreticulinHemoglobinuria, ParoxysmalHumansMaleMembrane ProteinsMiddle AgedMutationRepressor ProteinsThrombocythemia, EssentialASXL1 protein, humanCalreticulinCALR protein, humanMembrane Proteinsphosphatidylinositol glycan-class A proteinRepressor Proteins

Identifiers

PMID33491136
OpenAlexW3124388823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.